Aducanumab

Common Brands Actos
Drug Class
Thiazolidinedione
Controlled Substance Classification
Not a controlled medication
Generic Status
Lower-cost generic available
Availability
Prescription only
Allison Barnes, PharmD
Allison Barnes, PharmD
Read More
Medically reviewed by Allison Barnes, PharmD last update on 20/12/2023

Overview

Aducanumab, a pioneering Alzheimer’s treatment, represents a beacon of promise in the realm of neurodegenerative diseases. Engineered to combat amyloid plaques, notorious contributors to cognitive decline, this medication has emerged as a transformative force. Amidst the complexities of Alzheimer’s, Aducanumab’s unique approach offers renewed hope, potentially slowing the progression of this challenging condition.

 

As a focal point of medical innovation, its impact extends beyond conventional treatments, promising a more targeted and effective strategy in the ongoing battle against Alzheimer’s disease. Aducanumab stands at the forefront, embodying a paradigm shift in the pursuit of improved cognitive health.

DRUG STATUS

Availability

Prescription only

Pregnancy & Lactation

Pregnancy